References
[1] CFH gene variant Y402H, and smoking, body mass index, environmental associations with advanced age-related macular degeneration
Seddon J, George S, Rosner B, Klein M.
Hum Hered 2006; 61:157-165. DOI: 10.1159/000094141
Epidemiology Unit, Massachusetts Eye and Ear Infirmary, Department of Ophthalmology, Harvard Medical School, Department of Epidemiology, and Channing Laboratory, Harvard Medical School, Boston, Mass., Devers Eye Institute, Macular Degeneration Center, Casey Eye Institute, Oregon Health and Science University, P ortland, Oreg., USA johanna_seddon@yahoo.com
[2] Common variation in three genes, including a noncoding variant in CFH, strongly influence risk of age-related macular degeneration
Maller J, George S, Purcell S, Fagerness J, Altshuler D, Daly MJ, Seddon JM.
Nat Genet 2006; 38: 1055-1059
Center for Human Genetic Research, Massachusetts General Hospital, 185 Cambridge St., Boston, Massachusetts 02114, USA. Epidemiology Unit, Department of Ophthalmology, Massachusetts Eye and Ear Infirmary, 243 Charles St. Boston, Massachusetts 02114, USA. Program in Medical and Population Genetics, Broad Institute of Harvard and MIT, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA. Harvard Medical School, Boston, Massachusetts, USA. Correspondence should be addressed to J.M.S. (johanna_seddon@meei.harvard.edu) or M.J.D. (mjdaly@chgr.mgh.harvard.edu).
[3] Association of CFH Y402H and LOC387715 A69S with progression of age-related macular degeneration
Seddon JM, Francis PJ, George S, Schultz D, Rosner B, Klein ML.
JAMA 2007; 297:1793-1800.
American Medical Association, https://jamanetwork.com/
[4] Prediction model for prevalence and incidence of advanced age-related macular degeneration based on genetic, demographic, and environmental variables
Seddon JM, Reynolds R, Maller J, Fagerness JA, Daly MJ, Rosner B.
Invest Ophthalmol Vis Sci 2009; 50:2044-2053.
Ophthalmic Epidemiology and Genetics Service, Tufts University School of Medicine and Tufts Medical Center, Boston, Massachusetts. Center for Human Genetic Research, Massachusetts General Hospital and Program in Medical and Population Genetics, Broad Institute of Harvard and Massachusetts Institute of Technology, Boston, Massachusetts. Channing Laboratory, Harvard Medical School, Boston, Massachusetts
[5] Risk models for progression to advanced age-related macular degeneration using demographic, environmental, genetic, and ocular factors
Seddon JM, Reynolds R, Yu Y, Daly M, Rosner B.
Ophthalmology 2011; 118: 2203-2011.
Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Boston, Massachusetts, United States. Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States. Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States. Channing Division of Network Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts, United States
[6] Validation of a prediction algorithm for progression to advanced macular degeneration subtypes
Seddon JM, Reynolds R, Rosner B.
JAMA Ophthalmol 2013; 131: 448-449.
FromtheDepartmentofOphthalmologyandVisualSciences,Universityof Massachusetts MedicalSchool, Worcester, Massachusetts, USA(J.M.S.); and Channing Division of Network Medicine, Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA (B.R.). Inquiries to Johanna M. Seddon, PO Box 120065, Boston, MA 02112, USA; e-mail: johanna.seddon@umassmed.edu
[7] Three new genetic loci (R1210C, variants in COL8A1 and RAD51B) are independently related to progression to advanced macular degeneration
Seddon JM, Reynolds R, Yu Y, Rosner B.
PLoS ONE 2014; 9(1):e87047.doi:10.1371/journal.pone.0087047
Ophthalmic Epidemiology and Genetics Service, Tufts University School of Medicine and Tufts Medical Center, New England Eye Center, Boston, Massachusetts, United States of America, Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States of America, Channing Laboratory, Brigham and Women’s Hospital and Harvard School of Public Health, Harvard University, Boston, Massachusetts, United States of America
[8] Risk prediction for progression of macular degeneration: 10 common and rare genetic variants, demographic, environmental, and macular covariates
Seddon JM, Silver RE, Kwong M, Rosner B.
Invest Ophthalmol Vis Sci 2015; 56(4): 2192-202.
Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Boston, Massachusetts, United States. Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States. Sackler School of Graduate Biomedical Sciences, Tufts University, Boston, Massachusetts, United States. Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, Massachusetts, United States. Channing Division of Network Medicine, Harvard Medical School, Harvard University, Boston, Massachusetts, United States
[9] Optical Coherence Tomography Features Preceding the Onset of Advanced Age-Related Macular Degeneration
Seddon JM, Silver RE, Kwong M, Rosner B.
Ferrara D, Silver RE, Louzada RN, Novais EA, Collins GK, Seddon JM.
Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States. Ophthalmic Epidemiology and Genetics Service, New England Eye Center, Tufts Medical Center, Boston, Massachusetts, United States. Department of Ophthalmology, Federal University of Goi´as, Goiˆania, Brazil. Federal University of Sa˜o Paulo, School of Medicine, Sa˜o Paulo, Brazil. Sackler School of Graduate Biomedical Sciences and Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, United State
[10] Macular degeneration epidemiology: Nature-nurture, lifestyle factors, genetic risk, and gene-environment interactions-The Weisenfeld Award lecture
Seddon JM.
Invest Ophthalmol Vis Sci 2017; 58:6513-6528.
Ophthalmic Epidemiology and Genetics Service, Tufts Medical Center, Boston, Massachusetts, United States. Department of Ophthalmology, Tufts University School of Medicine, Boston, Massachusetts, United States. Sackler School of Graduate Biomedical Sciences and Friedman School of Nutrition Science and Policy, Tufts University, Boston, Massachusetts, United States
[11] Validated prediction models for macular degeneration progression and predictors of visual acuity loss identify high-risk individuals. AOS Thesis
Seddon JM, Rosner B. Am J.
Ophthalmol 2019; 198: 223-261.
American Medical Association, http://archopht.jamanetwork.com/

For other references and information, Click Here